共 224 条
[1]
Teoh Z(2020)COURAGE, ORBITA, and ISCHEMIA: percutaneous coronary intervention for stable coronary artery disease Interv Cardiol Clin 9 469-482
[2]
Al-Lamee RK(2018)Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club EuroIntervention 14 112-120
[3]
Burzotta F(2019)Are we ready for a gender-specific approach in interventional cardiology? Int J Cardiol 286 226-233
[4]
Lassen JF(2020)Coronary artery disease and acute coronary syndrome in women Heart 106 487-492
[5]
Banning AP(2021)Differences in coronary artery disease and outcomes of percutaneous coronary intervention with drug-eluting stents in women and men Expert Rev Cardiovasc Ther 19 301-312
[6]
Lefevre T(2018)Gender difference in clinical outcomes of the patients with coronary artery disease after percutaneous coronary intervention: A systematic review and meta-analysis Medicine (Baltimore) 97 e11644-424
[7]
Hildick-Smith D(2007)Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin Am J Cardiol 100 417-391
[8]
Chieffo A(1990)Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J Clin Invest 86 385-2216
[9]
Darremont O(2006)Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2203-959
[10]
Pan M(2001)Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study Am Heart J 142 952-863